Phase 2 Trial of Ixazomib, Cyclophosphamide and Dexamethasone for Treatment of Previously Untreated Light Chain Amyloidosis

This article has no abstract
Epistemonikos ID: d62f00909b808f5c379ea6dbc51adc1f32819cea
First added on: Feb 12, 2025